Amgen Inc. (AMGN) vs Eli Lilly and Company (LLY)
A side-by-side comparison of Amgen Inc. and Eli Lilly and Company across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.
AMGN
Amgen Inc.
$377.35HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT
LLY
Eli Lilly and Company
$1,115.25HealthcareDelayed quote: Sep 11, 2026, 3:59 PM EDT
Total return — AMGN vs LLY
growth of $100 · dividends reinvested · last 10yAMGN +201.9% (+11.7%/yr)LLY +1566.6% (+32.5%/yr)LLY compounded faster over this window
Log scale — wide-divergence pair
AMGN LLY
AMGN vs LLY: by the numbers
- •LLY is the larger company ($1.05T vs $203.66B market cap).
- •AMGN trades at the lower trailing earnings multiple (23.45 vs 37.42 P/E), one valuation lens rather than an overall verdict.
- •LLY converts more revenue to profit (33.53% vs 22.93% net margin).
- •LLY grew revenue faster over the past five years (24.42% vs 8.39% CAGR).
- •AMGN pays the higher dividend yield (2.56% vs 0.60%).
Metrics side by side
Valuation
| Metric | AMGN | LLY |
|---|---|---|
| P/E ratio | 23.45 | 37.42 |
| Forward P/E | 16.35 | 30.64 |
| P/S ratio | 5.34 | 13.18 |
| P/B ratio | 17.42 | 31.00 |
| EV / EBITDA | N/A | 29.91 |
| FCF yield | 5.00% | 1.91% |
Profitability
| Metric | AMGN | LLY |
|---|---|---|
| Gross margin | 72.65% | 84.01% |
| Operating margin | 33.18% | 43.92% |
| Net margin | 22.93% | 33.53% |
| ROE | 74.80% | 78.84% |
| ROIC | 14.22% | 27.38% |
Dividends
| Metric | AMGN | LLY |
|---|---|---|
| Dividend yield | 2.56% | 0.60% |
| Payout ratio | 60.91% | 22.45% |
Growth (annualized)
| Metric | AMGN | LLY |
|---|---|---|
| Revenue CAGR (5Y) | 8.39% | 24.42% |
| EPS CAGR (5Y) | 2.94% | 28.88% |
| FCF CAGR (5Y) | -3.91% | 32.91% |
| Total return CAGR (5Y) | 15.90% | 37.46% |
Frequently asked
- Which has the lower trailing P/E, AMGN or LLY?
- AMGN has the lower trailing P/E: AMGN trades at 23.45 and LLY at 37.42. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, AMGN or LLY?
- Over the past five years, LLY grew revenue faster — AMGN at a 8.39% CAGR versus LLY at 24.42%.
- Does AMGN or LLY pay a bigger dividend?
- AMGN yields 2.56% and LLY yields 0.60% based on trailing dividends and the latest price.
- Is AMGN or LLY more profitable?
- LLY runs the higher net margin — AMGN at 22.93% versus LLY at 33.53%.
- How have AMGN and LLY total returns compared?
- Over the past 10 years, AMGN delivered 11.95% and LLY delivered 32.58% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Amgen P/E ratioEli Lilly P/E ratioAmgen dividend yieldEli Lilly dividend yieldAmgen ROEEli Lilly ROEAmgen operating marginEli Lilly operating marginAmgen revenue growthEli Lilly revenue growthAmgen free cash flowEli Lilly free cash flow
Amgen & Eli Lilly appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.